Search Results for: search.php

Light weighted (insulating) boards

Scientists at the University of Göttingen developed new very light wood composites, boards and panels on renewable sources, replacing wood in a high percentage…

Monoclonale Antibodies: Anti-human Chemokine Receptor 5 (CCR5 / CD195);anti-CCR5-pSer 337 (PKC-site); mAbanti-CCR5-pSer349 (GRK

Scientists at the Georg-August-University Göttingen produced different monoclonal antibodies directed against phosphorylation sites of CCR5. These antibodies…

Monoclonal antibodies: Anti-human Chemokine Receptor 5 (CCR5 / CD195); anti-CCR5-pSer 337 (PKC-site); mAb anti-CCR5-pSer349 (GRK

Scientists at the Georg-August-University produced a monoclonal antibody which recognises murine CD197, a 43kD member of the G coupled receptor family, which…

Monoclonale Antibodies: Anti-human Chemokine Receptor 5 (CCR5 / CD195);anti-CCR5-pSer 337 (PKC-site); mAbanti-CCR5-pSer349 (GRK site)

Scientists at the Georg-August-University Göttingen produced different monoclonal antibodies directed against phosphorylation sites of CCR5. These antibodies have been demonstrated to exclusively recognise CD195 phosphorylated at Ser 337 or Ser 349. Human CD195 is a member of the G protein coupled superfamily of receptors, which acts as a receptor for a member of chemokines including RANTES and also serves as a co-receptor for the entry of HIV into cells. It plays a key role in regulating the activation and migration of leukocytes. CD195 is expressed by a subset of T-lymphocytes and by monocytes. Using these antibodies e.g. in combination with our indicator cell line ligand induced phosphorylation or dephosphorylation of CCR5 can be directly measured without using more indirect indicators like Ca++ concentrations.
This principle can be extended to measure activation states of G protein coupled receptors or activity of GPCR kinases generally, e.g. when screening for new agonists, antagonists or GRK inhibitors.

Form Or Function? Evolution Takes Different Paths

The research is scheduled for online publication in the Proceedings of the National Academy of Sciences during the week of April 5.In the study, U-M…

Prodrug for tumor therapy

Scientists of the University of Göttingen developed new highly potent drugs (with an IC50 in the pico-Molar range) as well as a selective tumor therapy through…

Seite
1 1,030 1,031 1,032 1,033 1,034 1,597